← Leaderboards
Richard M Longnecker
Northwestern University
$27,900,452
Attributed
$35,081,527
Total exposure
21
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,081,527 · 21
By mechanism
R01$32,418,555 · 13
R21$1,738,821 · 4
T32$577,609 · 1
P51$341,542 · 2
R13$5,000 · 1
Top collaborators
- Theodore S Jardetzky22 shared
- Z Hong Zhou7 shared
- Sarah A. Connolly5 shared
Most similar at Northwestern University
Same institution · by research overlap
- Theodore S Jardetzky$26,743,105
- Sarah A. Connolly$1,394,204
- Patricia G Spear$7,695,741
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusProteinsViralMediatingCellsInsightHerpesviridaeMalignant NeoplasmsB-LymphocytesReceptorHuman Herpesvirus 4GlycoproteinsMutationBaseSignal TransductionLeadInfectionMutantMolecularIn VitroEpstein-Barr Virus InfectionsSiteCell FusionLaboratories
Grant awards (112)
Epstein-Barr Virus Entry into Epithelial Cells$194,639
R21 · FY2025 · AI · contact PI
Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion$546,894
R01 · FY2024 · AI · contact PI
Epstein-Barr Virus Entry into Epithelial Cells$234,895
R21 · FY2024 · AI · contact PI
Receptor Usage and Regulation of the Immune Response in HSV Infection$194,748
R21 · FY2024 · AI · contact PI
Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion$546,894
R01 · FY2023 · AI · contact PI
Role of Host Cell Factors in Newborn Herpes Simplex Virus (HSV) Encephalitis$326,411
R01 · FY2023 · NS · contact PI
Receptor Usage and Regulation of the Immune Response in HSV Infection$234,997
R21 · FY2023 · AI · contact PI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry$704,020
R01 · FY2022 · AI · contact PI
Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion$546,894
R01 · FY2022 · AI · contact PI
Role of Host Cell Factors in Newborn Herpes Simplex Virus (HSV) Encephalitis$327,325
R01 · FY2022 · NS · contact PI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry$704,553
R01 · FY2021 · AI · contact PI
Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion$591,741
R01 · FY2021 · AI · contact PI
Role of Host Cell Factors in Newborn Herpes Simplex Virus (HSV) Encephalitis$328,198
R01 · FY2021 · NS · contact PI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry$705,245
R01 · FY2020 · AI · contact PI
Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion$555,984
R01 · FY2020 · AI · contact PI
Role of Host Cell Factors in Newborn Herpes Simplex Virus (HSV) Encephalitis$329,027
R01 · FY2020 · NS · contact PI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry$705,973
R01 · FY2019 · AI · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$378,639
R01 · FY2019 · EY · contact PI
Role of Host Cell Factors in Newborn Herpes Simplex Virus (HSV) Encephalitis$329,818
R01 · FY2019 · NS · contact PI
Structure and Function of EBV Protein Complexes that Trigger Epithelial Cell Entry$735,750
R01 · FY2018 · AI · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$378,639
R01 · FY2018 · EY · contact PI
In Vivo Model of Epstein-Barr Virus Latency$372,677
R01 · FY2018 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry$507,585
R01 · FY2017 · AI · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$378,639
R01 · FY2017 · EY · contact PI
In Vivo Model of Epstein-Barr Virus Latency$372,677
R01 · FY2017 · CA · contact PI
Herpesvirus Gene Expression in Transformed Cells$267,575
R01 · FY2017 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry$507,585
R01 · FY2016 · AI · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$378,639
R01 · FY2016 · EY · contact PI
In Vivo Model of Epstein-Barr Virus Latency$372,677
R01 · FY2016 · CA · contact PI
Inhibitors of the Epstein-Barr Virus Entry Machinery$331,208
R01 · FY2016 · CA
Herpesvirus Gene Expression in Transformed Cells$267,575
R01 · FY2016 · CA · contact PI
Structure and function of EBV protein complexes that trigger epithelial cell entry$195,417
R21 · FY2016 · AI
Nasopharyngeal Carcinoma Gordon Research Conference$5,000
R13 · FY2016 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry$507,585
R01 · FY2015 · AI · contact PI
In Vivo Model of Epstein-Barr Virus Latency$372,677
R01 · FY2015 · CA · contact PI
Inhibitors of the Epstein-Barr Virus Entry Machinery$331,208
R01 · FY2015 · CA
Herpesvirus Gene Expression in Transformed Cells$267,575
R01 · FY2015 · CA · contact PI
Structure and function of EBV protein complexes that trigger epithelial cell entry$264,750
R21 · FY2015 · AI
Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry$507,585
R01 · FY2014 · AI · contact PI
In Vivo Model of Epstein-Barr Virus Latency$372,677
R01 · FY2014 · CA · contact PI
Inhibitors of the Epstein-Barr Virus Entry Machinery$321,272
R01 · FY2014 · CA
Herpesvirus Gene Expression in Transformed Cells$259,547
R01 · FY2014 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry$490,755
R01 · FY2013 · AI · contact PI
Inhibitors of the Epstein-Barr Virus Entry Machinery$311,336
R01 · FY2013 · CA
Herpesvirus Gene Expression in Transformed Cells$267,575
R01 · FY2013 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class II in EBV Entry$398,587
R01 · FY2012 · AI · contact PI
In Vivo Model of Epstein-Barr Virus Latency$366,175
R01 · FY2012 · CA · contact PI
Inhibitors of the Epstein-Barr Virus Entry Machinery$345,458
R01 · FY2012 · CA
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$273,533
R01 · FY2012 · CA · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$190,625
R21 · FY2012 · EY · contact PI
Training Program in Viral Replication$144,172
T32 · FY2012 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$79,381
R01 · FY2012 · CA · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$402,448
R01 · FY2011 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class II in EBV Entry$400,947
R01 · FY2011 · AI · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$370,678
R01 · FY2011 · AI · contact PI
In Vivo Model of Epstein-Barr Virus Latency$366,175
R01 · FY2011 · CA · contact PI
Role of Host Cell Factors in Herpes Simplex Virus (HSV) Keratitis$228,750
R21 · FY2011 · EY · contact PI
Training Program in Viral Replication$132,143
T32 · FY2011 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$79,631
R01 · FY2011 · CA · contact PI
In Vivo Model of Epstein-Barr Virus Latency$499,500
R01 · FY2010 · CA · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$417,031
R01 · FY2010 · AI · contact PI
Structural and Functional Studies of gp42 and HLA Class II in EBV Entry$411,741
R01 · FY2010 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$274,204
R01 · FY2010 · CA · contact PI
Herpesvirus gene expression in transformed cells$261,514
R01 · FY2010 · CA · contact PI
Training Program in Viral Replication$151,088
T32 · FY2010 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$134,365
R01 · FY2010 · CA · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$82,361
R01 · FY2010 · CA · contact PI
In Vivo Model of Epstein-Barr Virus Latency$499,500
R01 · FY2009 · CA · contact PI
Structural and Functional Studies of gp42 and HLA Class II in EBV Entry$416,143
R01 · FY2009 · AI · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$365,285
R01 · FY2009 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$274,204
R01 · FY2009 · CA · contact PI
Herpesvirus gene expression in transformed cells$261,514
R01 · FY2009 · CA · contact PI
Training Program in Viral Replication$150,206
T32 · FY2009 · AI · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$40,690
R01 · FY2009 · AI · contact PI
Structural and Functional Studies of gp42 and HLA Class II in EBV Entry$430,471
R01 · FY2008 · AI · contact PI
In Vivo Model of Epstein-Barr Virus Latency$377,500
R01 · FY2008 · CA · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$365,578
R01 · FY2008 · AI · contact PI
Discovery of New Treatment Options for EBV-associated Lymphoma and PTLD$274,204
R01 · FY2008 · CA · contact PI
DETERMINATION OF THE IMPORTANCE OF LMP2A IN PRIMARY EBV INFECTION$237,907
P51 · FY2008 · RR · contact PI
EBV gB Function in Viral Fusion, Entry, and Egress$363,158
R01 · FY2007 · AI · contact PI
Biochemical and Genetic Studies of Latent Membrane Pro 2$264,713
R01 · FY2007 · CA · contact PI
DETERMINATION OF THE IMPORTANCE OF LMP2A IN PRIMARY EBV INFECTION$103,635
P51 · FY2007 · RR · contact PI
Functional Studies of gp42 and HLA Class 11 in EBV$365,107
R01 · FY2006 · CA · contact PI
Biochemical and Genetic Studies of Latent Membrane Pro 2$272,619
R01 · FY2006 · CA · contact PI
In Vivo Model of Epstein-Barr Virus Latency$265,941
R01 · FY2006 · CA · contact PI
In Vivo Model of Epstein-Barr Virus Latency$99,999
R01 · FY2006 · CA · contact PI
Functional Studies of gp42 and HLA Class 11 in EBV$363,002
R01 · FY2005 · CA
Biochemical and Genetic Studies of Latent Membrane Pro 2$279,180
R01 · FY2005 · CA
In Vivo Model of Epstein-Barr Virus Latency$272,342
R01 · FY2005 · CA
Functional Studies of gp42 and HLA Class 11 in EBV$352,430
R01 · FY2004 · CA
Biochemical and Genetic Studies of Latent Membrane Pro 2$279,180
R01 · FY2004 · CA
In Vivo Model of Epstein-Barr Virus Latency$272,342
R01 · FY2004 · CA
Biochemical and Genetic Studies of Latent Membrane Pro 2$6,683
R01 · FY2004 · CA
Functional Studies of gp42 and HLA Class 11 in EBV$342,162
R01 · FY2003 · CA
Biochemical and Genetic Studies of Latent Membrane Pro 2$279,415
R01 · FY2003 · CA
THE ROLE OF EPSTEIN-BARR VIRUS EBNA1, LMP1 AND LMP2A PRO$275,100
R01 · FY2003 · DE
In Vivo Model of Epstein-Barr Virus Latency$272,342
R01 · FY2003 · CA
In Vivo Model of Epstein-Barr Virus Latency$100,000
R01 · FY2003 · CA
Functional Studies of gp42 and HLA Class 11 in EBV$345,546
R01 · FY2002 · CA
EBV LATENT MEMBRANE PROTEIN 2$274,547
R01 · FY2002 · CA
In Vivo Model of Epstein-Barr Virus Latency$273,211
R01 · FY2002 · CA
THE ROLE OF EPSTEIN-BARR VIRUS EBNA1, LMP1 AND LMP2A PRO$257,690
R01 · FY2002 · DE
EBV LATENT MEMBRANE PROTEIN 2$267,812
R01 · FY2001 · CA
THE ROLE OF EPSTEIN-BARR VIRUS EBNA1, LMP1 AND LMP2A PRO$251,348
R01 · FY2001 · DE
IN VIVO MODEL OF EBV LATENCY$225,134
R01 · FY2001 · CA
IN VIVO MODEL OF EBV LATENCY$49,543
R01 · FY2001 · CA
EBV LATENT MEMBRANE PROTEIN 2$6,737
R01 · FY2001 · CA
THE ROLE OF EPSTEIN-BARR VIRUS EBNA1, LMP1 AND LMP2A PRO$236,195
R01 · FY2000 · DE
IN VIVO MODEL OF EBV LATENCY$218,634
R01 · FY2000 · CA
EBV LATENT MEMBRANE PROTEIN 2$217,971
R01 · FY2000 · CA
IN VIVO MODEL OF EBV LATENCY$48,100
R01 · FY2000 · CA
EBV LATENT MEMBRANE PROTEIN 2$42,920
R01 · FY2000 · CA